Ha-Eun Cho

Turnaround Time (TAT) Setting Status of 30 Domestic Clinical Laboratories and Consideration for Improvement and Management of TAT

Jeong-Ho Kim, Yong-Wha Lee, S. Cho, 2020 .

The First Case of B-lymphoblastic Leukemia Associated With t(7;8)(q34;p11.2) and FGFR1 Rearrangement

S. Cho, Woo-In Lee, T. Park, 2022, Annals of laboratory medicine.

First Case Report of Acute Myeloid Leukemia with MN1-ETV6 Rearrangement at Relapse

Woo-In Lee, T. Park, Young Jin Kim, 2021, Laboratory Medicine Online.

Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer

Tae-You Kim, J. W. Kim, Keun-Wook Lee, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

CDK12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS1-ErbB-PI3K signaling.

G. Kong, Hyung-Yong Kim, Jeong-Yeon Lee, 2019, EMBO reports.

PHI-101 Is a Potent Third-Generation FLT3 Inhibitor Developed to Overcome Resistance in Acute Myeloid Leukemia

Ky-Youb Nam, D. Small, Li Li, 2020 .

Clinical application of an algorithm to screen for malignant cells in body fluids using an automated hematology analyzer

T. Park, Young Jin Kim, Kyung-Sun Park, 2022, International journal of laboratory hematology.